Could a dissolvable scaffold and your own fat replace silicone breast implants?
NCT ID NCT05437757
First seen Jul 10, 2026 · Last updated Jul 10, 2026
Summary
This trial tests a new approach for women needing breast implant revision or correction of a congenital breast defect. Surgeons implant a 3D-printed, absorbable scaffold and inject the patient's own fat cells harvested from another body area. The scaffold acts as a temporary frame that dissolves over about three years, leaving behind the patient's natural tissue. The study aims to see if this method is safe and effective for regenerating soft breast tissue without a permanent implant.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 3D-printed polycaprolactone breast scaffold with autologous fat grafting
- What this could lead to
- If successful, this could offer a natural alternative to silicone implants for breast revision or congenital defect correction, using the body's own tissue.
- What could go wrong
- This is an early feasibility study with only 19 participants. The scaffold may not support adequate tissue growth, and risks include infection, fat absorption, or asymmetry.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST IMPLANT REVISION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Brisbane and Women's Hospital (RBWH)
Brisbane, Queensland, QLD 4029, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.